OGN.NYSEOrganon & CO

Form 4: Organon & Co. Executive Susanne Fiedler Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Organon & CO
🔒Login to Follow

Chief Commercial Officer Susanne Fiedler reports the vesting and subsequent disposal of Organon & Co. stock units on March 31, 2024.

Summary

  • Susanne Fiedler, Chief Commercial Officer of Organon & Co., reported transactions involving Organon & Co. common stock on March 31, 2024.
  • The transactions involved the vesting of restricted stock units (RSUs) and the subsequent disposal of shares to cover tax obligations.
  • Specifically, 4,771 RSUs vested and were converted into common stock, followed by the disposal of 1,520 shares at $18.80.
  • Additionally, 7,794 RSUs vested and were converted into common stock, followed by the disposal of 2,483 shares at $18.80.
  • Following these transactions, Fiedler directly owns 47,264 shares of Organon & Co. common stock and 15,590 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.

Key Dates

DateDescription
03/31/2023One-third of the initially granted RSUs vested.
03/31/2024Vesting of RSUs and subsequent stock disposal occurred.
03/31/2025Remaining RSUs from the first grant to vest.
03/31/2025One-half of the remaining RSUs from the second grant to vest.
03/31/2026Remaining RSUs from the second grant to vest.
04/03/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.